59 related articles for article (PubMed ID: 27376492)
21. Metabolism of KO143, an ABCG2 inhibitor.
Liu K; Zhu J; Huang Y; Li C; Lu J; Sachar M; Li S; Ma X
Drug Metab Pharmacokinet; 2017 Aug; 32(4):193-200. PubMed ID: 28619281
[TBL] [Abstract][Full Text] [Related]
22. Phenyltetrazolyl-phenylamides: Substituent impact on modulation capability and selectivity toward the efflux protein ABCG2 and investigation of interaction with the transporter.
Köhler SC; Silbermann K; Wiese M
Eur J Med Chem; 2016 Nov; 124():881-895. PubMed ID: 27676469
[TBL] [Abstract][Full Text] [Related]
23. Chromones: Privileged scaffold in anticancer drug discovery.
Patil VM; Masand N; Verma S; Masand V
Chem Biol Drug Des; 2021 Nov; 98(5):943-953. PubMed ID: 34519163
[TBL] [Abstract][Full Text] [Related]
24. Acryloylphenylcarboxamides: A New Class of Breast Cancer Resistance Protein (ABCG2) Modulators.
Kraege S; Köhler SC; Wiese M
ChemMedChem; 2016 Nov; 11(21):2422-2435. PubMed ID: 27735138
[TBL] [Abstract][Full Text] [Related]
25. Challenges with chromone as a privileged scaffold in drug discovery.
Silva CFM; Batista VF; Pinto DCGA; Silva AMS
Expert Opin Drug Discov; 2018 Sep; 13(9):795-798. PubMed ID: 29985064
[No Abstract] [Full Text] [Related]
26. Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
Kim MK; Yoon H; Barnard DL; Chong Y
Chem Pharm Bull (Tokyo); 2013; 61(4):486-8. PubMed ID: 23546009
[TBL] [Abstract][Full Text] [Related]
27. Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances.
Reis J; Gaspar A; Milhazes N; Borges F
J Med Chem; 2017 Oct; 60(19):7941-7957. PubMed ID: 28537720
[TBL] [Abstract][Full Text] [Related]
28. One-step synthesis of diaryloxadiazoles as potent inhibitors of BCRP.
Yi W; Tran-Nguyen VK; Boumendjel A
Future Med Chem; 2024 Apr; 16(8):723-35. PubMed ID: 38573062
[No Abstract] [Full Text] [Related]
29. ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
Damiani D; Tiribelli M
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255216
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of cold gas plasma and experimental drug exposure exhibits skin cancer toxicity in vitro and in vivo.
Boeckmann L; Berner J; Kordt M; Lenz E; Schäfer M; Semmler ML; Frey A; Sagwal SK; Rebl H; Miebach L; Niessner F; Sawade M; Hein M; Ramer R; Grambow E; Seebauer C; von Woedtke T; Nebe B; Metelmann HR; Langer P; Hinz B; Vollmar B; Emmert S; Bekeschus S
J Adv Res; 2024 Mar; 57():181-196. PubMed ID: 37391038
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Potent ABCG2 Inhibitor Derived from Chromone: From the Mechanism of Inhibition to Human Extracellular Vesicles for Drug Delivery.
Valdameri G; Kita DH; Dutra JP; Gomes DL; Tonduru AK; Kronenberger T; Gavinho B; Rossi IV; Carvalho MM; Pérès B; Zattoni IF; Rego FGM; Picheth G; Freitas RA; Poso A; Ambudkar SV; Ramirez MI; Boumendjel A; Moure VR
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111745
[TBL] [Abstract][Full Text] [Related]
32. Development of Simple and Accurate in Silico Ligand-Based Models for Predicting ABCG2 Inhibition.
Huang S; Gao Y; Zhang X; Lu J; Wei J; Mei H; Xing J; Pan X
Front Chem; 2022; 10():863146. PubMed ID: 35665065
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.
Dei S; Braconi L; Romanelli MN; Teodori E
Cancer Drug Resist; 2019; 2(3):710-743. PubMed ID: 35582565
[TBL] [Abstract][Full Text] [Related]
34. Tetrahydroquinoline/4,5-Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2).
Vesga LC; Kronenberger T; Tonduru AK; Kita DH; Zattoni IF; Bernal CC; Bohórquez ARR; Mendez-Sánchez SC; Ambudkar SV; Valdameri G; Poso A
ChemMedChem; 2021 Sep; 16(17):2686-2694. PubMed ID: 33844464
[TBL] [Abstract][Full Text] [Related]
35. ADMET evaluation in drug discovery. 20. Prediction of breast cancer resistance protein inhibition through machine learning.
Jiang D; Lei T; Wang Z; Shen C; Cao D; Hou T
J Cheminform; 2020 Mar; 12(1):16. PubMed ID: 33430990
[TBL] [Abstract][Full Text] [Related]
36. From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.
Alarcón-Espósito J; Mallea M; Rodríguez-Lavado J
Curr Neuropharmacol; 2021; 19(6):832-867. PubMed ID: 32928087
[TBL] [Abstract][Full Text] [Related]
37. Novel Methylselenoesters as Antiproliferative Agents.
Díaz-Argelich N; Encío I; Plano D; Fernandes AP; Palop JA; Sanmartín C
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767087
[TBL] [Abstract][Full Text] [Related]
38. Phomopsichin A-D; Four New Chromone Derivatives from Mangrove Endophytic Fungus Phomopsis sp. 33.
Huang M; Li J; Liu L; Yin S; Wang J; Lin Y
Mar Drugs; 2016 Nov; 14(11):. PubMed ID: 27879655
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
